Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Biomerica, Inc. (BMRA)

0.8602   0.04 (4.9%) 09-29 15:58
Open: 0.86 Pre. Close: 0.82
High: 0.9 Low: 0.8201
Volume: 20,045 Market Cap: 14(M)

Technical analysis

as of: 2023-09-29 4:26:15 PM
Short-term rate:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Mid-term rate:       
Target: Six months: 1.33     One year: 1.56
Support: Support1: 0.81    Support2: 0.68
Resistance: Resistance1: 1.14    Resistance2: 1.34
Pivot: 1.02
Moving Average: MA(5): 0.9     MA(20): 1.08
MA(100): 1.3     MA(250): 2.25
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 6.3     %D(3): 8.4
RSI: RSI(14): 27.9
52-week: High: 5.25  Low: 0.81
Average Vol(K): 3-Month: 241 (K)  10-Days: 64 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BMRA ] has closed above bottom band by 7.1%. Bollinger Bands are 6.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.9 - 0.91 0.91 - 0.91
Low: 0.81 - 0.81 0.81 - 0.82
Close: 0.85 - 0.86 0.86 - 0.87

Company Description

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

Headline News

Tue, 26 Sep 2023
Cantor Fitzgerald Analyst Reaffirms Neutral Rating and 4 Price ... - Best Stocks

Tue, 26 Sep 2023
Biomerica, Inc. (BMRA) Announces Dubai Government Grants ... -

Mon, 28 Aug 2023
Diagnostics Industry Leader Jack Kenny Joins Biomerica's - GlobeNewswire

Fri, 25 Aug 2023
Biomerica Reports Fiscal 2023 Year End Results - GlobeNewswire

Thu, 03 Aug 2023
CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test - Yahoo Finance

Thu, 03 Aug 2023
Is Biomerica Inc (BMRA) Stock a Smart Investment Thursday? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 17 (M)
Shares Float 16 (M)
% Held by Insiders 7.2 (%)
% Held by Institutions 33.1 (%)
Shares Short 476 (K)
Shares Short P.Month 345 (K)

Stock Financials

EPS -0.47
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.69
Profit Margin (%) -133.8
Operating Margin (%) -129.9
Return on Assets (ttm) -33.6
Return on Equity (ttm) -71.3
Qtrly Rev. Growth -79.1
Gross Profit (p.s.) 0.02
Sales Per Share 0.31
EBITDA (p.s.) -0.41
Qtrly Earnings Growth 0
Operating Cash Flow -5 (M)
Levered Free Cash Flow -2 (M)

Stock Valuations

PE Ratio -1.83
PEG Ratio 0
Price to Book value 1.22
Price to Sales 2.7
Price to Cash Flow -2.64

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.